Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni

Applied and Environmental Microbiology

Volumn 77, Issue 7, 2011, Pages 2325-2331

  Xie, Yanping ^a   He, Yiping ^b   Irwin, Peter L ^b   Jin, Tony ^b   Shi, Xianming ^a  

^a China   (China)

^b EASTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL EFFECTS; BACTERIOSTATIC; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERS; ESCHERICHIA COLI O157:H7; ETHIDIUM MONOAZIDE; EXPRESSION LEVELS; IN-CELL; INACTIVATION OF CELLS; MECHANISM OF ACTION; MEMBRANE LEAKAGES; MOLECULAR BASIS; MORPHOLOGICAL CHANGES; QUANTITATIVE PCR; REVERSE TRANSCRIPTION; SALMONELLA ENTERICA; SEROVAR; SPIRAL SHAPE; STRESS CONDITION; STRESS RESPONSE GENES; TOXIN PRODUCTION; ZINC OXIDE NANOPARTICLES; ZNO; ZNO NANOPARTICLES;

CELL MEMBRANES; CYTOLOGY; ESCHERICHIA COLI; GENES; GROWTH KINETICS; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TRANSCRIPTION; ZINC; ZINC OXIDE;

NANOPARTICLES;

ANTIINFECTIVE AGENT; NANOPARTICLE; ZINC OXIDE;

BACTERIUM; GENE; INHIBITION; MEMBRANE; MOTILITY; NANOTECHNOLOGY; PATHOGENICITY; SCANNING ELECTRON MICROSCOPY; TOXIN; TRANSFORMATION; ZINC;

ARTICLE; CAMPYLOBACTER JEJUNI; CELL MEMBRANE PERMEABILITY; DRUG EFFECT; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; OXIDATIVE STRESS; SALMONELLA ENTERITIDIS;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER JEJUNI; CELL MEMBRANE PERMEABILITY; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; NANOPARTICLES; OXIDATIVE STRESS; SALMONELLA ENTERITIDIS; ZINC OXIDE;

CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; COCCOIDEA; ESCHERICHIA COLI; SALMONELLA ENTERITIDIS;

EID: 79953276209     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02149-10     Document Type: Article

References (29)

1. Adams, B. L., T. C. Bates, and J. D. Oliver. 2003. Survival of Helicobacter pylori in a natural freshwater environment. Appl. Environ. Microbiol. 69: 7462-7466.
2. Arsène, F., T. Tomoyasu, and B. Bukau. 2000. The heat shock response of Escherichia coli. Int. J. Food Microbiol. 55:3-9.
3. Baillon, M. L., A. H. van Vliet, J. M. Ketley, C. Constantinidou, and C. W. Penn. 1999. An iron-regulated alkyl hydroperoxide reductase (AhpC) confers aerotolerance and oxidative stress resistance to the microaerophilic pathogen Campylobacter jejuni. J. Bacteriol. 181:4798-4804.
4. Brayner, R., et al. 2006. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett. 6:866-870.
5. Catrenich, C. E., and K. M. Makin. 1991. Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand. J. Gastroenterol. Suppl. 181:58-64.
6. Fu, G., P. S. Vary, and C. T. Lin. 2005. Anatase TiO2 nanocomposites for antimicrobial coatings. J. Phys. Chem. B 109:8889-8898.
7. Grant, K., and S. Park. 1995. Molecular characterization of katA from Campylobacter jejuni and generation of a catalase-deficient mutant of Campylobacter coli by interspecific allelic exchange. Microbiology 141:1369-1376.
8. He, Y., J. G. Frye, T. P. Strobaugh, and C. Y. Chen. 2008. Analysis of AI-2/LuxS-dependent transcription in Campylobacter jejuni strain 81-176. Foodborne Pathog. Dis. 5:399-415.
9. He, Y., et al. 2010. Simultaneous detection and differentiation of Campylobacter jejuni, C. coli, and C. lari in chickens using a multiplex real-time PCR assay. Food Anal. Methods 137:168-174.
10. He, Y. P., and C. Y. Chen. 2010. Quantitative analysis of viable, stressed and dead cells of Campylobacter jejuni strain 81-176. Food Microbiol. 27:439-446.
11. Jacobs-Reitsma, W. F., U. Lyhs, and J. Wagenaar. 2008. Campylobacter in the food supply, p. 627-644. In I. Nachamkin, C. M. Szymanski, and M. J. Blaser (ed.), Campylobacter, 3rd ed. ASM Press, Washington, DC.
12. Jin, T., D. Sun, J. Y. Su, H. Zhang, and H. J. Sue. 2009. Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella Enteritidis, and Escherichia coli O157:H7. J. Food Sci. 74:M46-M52.
13. Jones, N., B. Ray, K. T. Ranjit, and A. C. Manna. 2008. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol. Lett. 279:71-76.
14. Liu, Y., et al. 2009. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. J. Appl. Microbiol. 107:1193-1201.
15. -ΔΔCT method. Methods 25:402-408.
16. Nair, S., et al. 2009. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J. Mater. Sci. Mater. Med. 20(Suppl. 1):S235-S241.
17. Nogva, H. K., S. M. Dromtorp, H. Nissen, and K. Rudi. 2003. Ethidium monoazide for DNA-based differentiation of viable and dead bacteria by 5'-nuclease PCR. Biotechniques 34:804-813.
18. Padmavathy, N., and R. Vijayaraghavan. 2008. Enhanced bioactivity of ZnO nanoparticles-an antimicrobial study. Sci. Technol. Adv. Mater. 9:1-7.
19. Petersdorf, R. G., and J. C. Sherris. 1965. Methods and significance of in vitro testing of bacterial sensitivity to drugs. Am. J. Med. 39:766-779.
20. Purdy, D., S. Cawthraw, J. H. Dickinson, D. G. Newell, and S. F. Park. 1999. Generation of a superoxide dismutase (SOD)-deficient mutant of Campylobacter coli: evidence for the significance of SOD in Campylobacter survival and colonization. Appl. Environ. Microbiol. 65:2540-2546.
21. Reddy, K. M., et al. 2007. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 90:2139021-2139023.
22. Sawai, J. 2003. Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. J. Microbiol. Methods 54:177-182.
23. Sawai, J., et al. 1996. Detection of active oxygen generated from ceramic powders having antibacterial activity. J. Chem. Eng. Jpn. 29:627-633.
24. Stoimenov, P. K., R. L. Klinger, G. L. Marchin, and K. J. Klabunde. 2002. Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679-6686.
25. Tangwatcharin, P., S. Chanthachum, P. Khopaibool, and M. W. Griffiths. 2006. Morphological and physiological responses of Campylobacter jejuni to stress. J. Food. Prot. 69:2747-2753.
26. van Vliet, A. H., J. M. Ketley, S. F. Park, and C. W. Penn. 2002. The role of iron in Campylobacter gene regulation, metabolism and oxidative stress defense. FEMS Microbiol. Rev. 26:173-186.
27. Yamamoto, O., M. Komatsu, J. Sawai, and Z. E. Nakagawa. 2004. Effect of lattice constant of zinc oxide on antibacterial characteristics. J. Mater Sci. Mater. Med. 15:847-851.
28. Yuki, N., and M. Koga. 2006. Bacterial infections in Guillain-Barré and Fisher syndromes. Curr. Opin. Neurol. 19:451-457.
29. Zhang, L. L., Y. H. Jiang, Y. L. Ding, M. Povey, and D. York. 2007. Investigation into the antibacterial behavior of suspensions of ZnO nanoparticles (ZnO nanofluids). J. Nanopart. Res. 9:479-489.